Hepatitis C Presentation for CHOW 2011
•Download as PPTX, PDF•
8 likes•4,927 views
This document provides information about viral hepatitis, focusing on hepatitis A, B, and C. It discusses the transmission, symptoms, diagnosis, and long-term effects of each virus. Hepatitis A and B can be prevented through vaccines, while hepatitis C has no vaccine and is transmitted through blood. Over time, untreated hepatitis C can lead to cirrhosis or liver cancer, though many people have no symptoms for decades. Genotypes determine treatment options for hepatitis C.
Report
Share
Report
Share
Recommended
Hepatitis C presentation
The document provides information on Hepatitis C virus (HCV) including its definition, background prevalence data, transmission routes, screening and testing approaches, natural history, symptoms, treatment options, and standard precautions. It notes that HCV is a blood-borne virus that infects the liver and is transmitted through exposure to infected blood. An estimated 3% of the global population has been infected with HCV.
Hcv don crocock
This document provides information about Hepatitis C, including:
- Hepatitis C is a blood-borne virus that affects the liver and can lead to fibrosis and cirrhosis if left untreated.
- An estimated 300,000 Canadians are infected with Hepatitis C, many unknowingly due to a lack of symptoms.
- New direct-acting antiviral treatments have revolutionized treatment by providing pan-genotypic regimens without interferon in most cases.
- Access to treatment and support is being expanded through 17 new HCV Teams across Canada.
Hepatitis c
Hepatitis C is a major global public health problem that infects approximately 180 million people worldwide. It is a leading cause of liver disease and death, with more than 350,000-500,000 people dying each year from hepatitis C related liver disease. The virus predominantly causes chronic infection in 70-85% of cases and can lead to cirrhosis, liver failure, and hepatocellular carcinoma over time if left untreated. New direct acting antiviral regimens have revolutionized treatment and now offer cure rates over 95% with shorter, better tolerated courses of therapy.
Viral hepatitis c. corrected
A 45-year-old woman presents with fatigue, weakness, loss of appetite, and abnormal liver function tests. Laboratory results show elevated AST, ALT, bilirubin levels and positive tests for HCV antibody and RNA. A liver biopsy revealed severe inflammation and bridging fibrosis. The patient is diagnosed with chronic hepatitis C virus infection based on her history of blood transfusion, symptoms, laboratory abnormalities and biopsy findings. The best course of action is to treat her HCV infection with antiviral therapy to reduce liver damage and prevent progression to cirrhosis.
The HCV Treatment Revolution: A View from the Community Health Center
The HCV Treatment Revolution: A View from the Community Health Center UC San Diego AntiViral Research Center
Christian B. Ramers, M.D., M.P.H., of Family Health Centers of San Diego, presents "The HCV Treatment Revolution: A View from the Community Health Center" for AIDS Clinical Rounds at UC San Diego Hepatitis C virus
The document provides information about the liver and Hepatitis C virus. It discusses the anatomy and function of the liver, as well as the causes, symptoms, diagnosis, and treatment of Hepatitis C. Regarding Hepatitis C specifically, it notes that there are over 150 million chronic cases globally, it is transmitted through blood and bodily fluids, and while there is no vaccine, many new highly effective drug regimens have been developed to cure over 95% of cases. The document provides a comprehensive overview of Hepatitis C for medical students and healthcare professionals.
Hepatitis C and its Treatment
This document discusses hepatitis C virus (HCV) and its treatment. It begins by defining hepatitis as inflammation of the liver and describing the various causes, including viral hepatitis from hepatitis viruses A-E. It then focuses on HCV, describing it as an RNA virus that infects liver cells. The document discusses HCV transmission, signs and symptoms, natural progression to chronic infection, and treatment options to cure HCV including various antiviral medications like interferons, ribavirin, boceprevir, and sofosbuvir. It provides details on treatment regimens and success rates depending on HCV genotype.
HEPATITIS C VIRUS
Help manage stress and improve quality of life, but do not cure hepatitis C. Seek medical advice before trying any complementary therapies.
Recommended
Hepatitis C presentation
The document provides information on Hepatitis C virus (HCV) including its definition, background prevalence data, transmission routes, screening and testing approaches, natural history, symptoms, treatment options, and standard precautions. It notes that HCV is a blood-borne virus that infects the liver and is transmitted through exposure to infected blood. An estimated 3% of the global population has been infected with HCV.
Hcv don crocock
This document provides information about Hepatitis C, including:
- Hepatitis C is a blood-borne virus that affects the liver and can lead to fibrosis and cirrhosis if left untreated.
- An estimated 300,000 Canadians are infected with Hepatitis C, many unknowingly due to a lack of symptoms.
- New direct-acting antiviral treatments have revolutionized treatment by providing pan-genotypic regimens without interferon in most cases.
- Access to treatment and support is being expanded through 17 new HCV Teams across Canada.
Hepatitis c
Hepatitis C is a major global public health problem that infects approximately 180 million people worldwide. It is a leading cause of liver disease and death, with more than 350,000-500,000 people dying each year from hepatitis C related liver disease. The virus predominantly causes chronic infection in 70-85% of cases and can lead to cirrhosis, liver failure, and hepatocellular carcinoma over time if left untreated. New direct acting antiviral regimens have revolutionized treatment and now offer cure rates over 95% with shorter, better tolerated courses of therapy.
Viral hepatitis c. corrected
A 45-year-old woman presents with fatigue, weakness, loss of appetite, and abnormal liver function tests. Laboratory results show elevated AST, ALT, bilirubin levels and positive tests for HCV antibody and RNA. A liver biopsy revealed severe inflammation and bridging fibrosis. The patient is diagnosed with chronic hepatitis C virus infection based on her history of blood transfusion, symptoms, laboratory abnormalities and biopsy findings. The best course of action is to treat her HCV infection with antiviral therapy to reduce liver damage and prevent progression to cirrhosis.
The HCV Treatment Revolution: A View from the Community Health Center
The HCV Treatment Revolution: A View from the Community Health Center UC San Diego AntiViral Research Center
Christian B. Ramers, M.D., M.P.H., of Family Health Centers of San Diego, presents "The HCV Treatment Revolution: A View from the Community Health Center" for AIDS Clinical Rounds at UC San Diego Hepatitis C virus
The document provides information about the liver and Hepatitis C virus. It discusses the anatomy and function of the liver, as well as the causes, symptoms, diagnosis, and treatment of Hepatitis C. Regarding Hepatitis C specifically, it notes that there are over 150 million chronic cases globally, it is transmitted through blood and bodily fluids, and while there is no vaccine, many new highly effective drug regimens have been developed to cure over 95% of cases. The document provides a comprehensive overview of Hepatitis C for medical students and healthcare professionals.
Hepatitis C and its Treatment
This document discusses hepatitis C virus (HCV) and its treatment. It begins by defining hepatitis as inflammation of the liver and describing the various causes, including viral hepatitis from hepatitis viruses A-E. It then focuses on HCV, describing it as an RNA virus that infects liver cells. The document discusses HCV transmission, signs and symptoms, natural progression to chronic infection, and treatment options to cure HCV including various antiviral medications like interferons, ribavirin, boceprevir, and sofosbuvir. It provides details on treatment regimens and success rates depending on HCV genotype.
HEPATITIS C VIRUS
Help manage stress and improve quality of life, but do not cure hepatitis C. Seek medical advice before trying any complementary therapies.
Hepatitis c (hcv)
Hepatitis C is an infection caused by the hepatitis C virus (HCV), which attacks liver cells and causes liver inflammation.
Basics of Hepatitis C
Hepatitis C is a viral infection of the liver caused by the hepatitis C virus (HCV). HCV is a spherical enveloped RNA virus that exists in 7 genotypes globally. It has structural and non-structural proteins and can cause both acute and chronic liver disease. HCV is transmitted primarily through contaminated blood and reuse of injection needles. While most infected individuals are asymptomatic, chronic infection can progress to cirrhosis or liver cancer over decades. Newer direct-acting antiviral drugs can cure over 95% of HCV infections with shorter treatment durations.
Hepatitis c
Hepatitis C is a contagious liver disease that can range from a mild illness lasting a few weeks to a serious lifelong condition. Acute hepatitis C occurs within the first 6 months of exposure and often leads to chronic infection. Chronic hepatitis C can last a lifetime and significantly damage the liver, possibly causing cirrhosis or liver cancer. The virus is primarily spread through contact with infected blood and affects an estimated 3.2 million Americans, with baby boomers most at risk. While treatment is very effective at clearing the virus, hepatitis C was responsible for over 350,000 deaths worldwide in recent years.
Epidemiology of Hepatitis C Virus in Egypt; an overview
This lecture is about Epidemiology of HCV in Egypt presented by Prof. DeWolfe Miller, Professor of Epidemiology, Hawaii University.
The lecture was presented in the scientific meeting of Internal and Tropical Medicine departments, Ahmed Maher Teaching Hospital titled (Towards Eradication of HCV in Egypt) in celebration of World Hepatitis Day on July 28, 2016.
https://www.facebook.com/AMTH.IM
https://www.facebook.com/events/1072758396145209/
http://www.no4c.com
Hepatitis C Treatment Questions
This document discusses hepatitis C virus (HCV) and current treatment options. It provides the following key points:
- HCV is the most common blood-borne pathogen in the US, with around 3.2 million people chronically infected. Chronic infections often progress to cirrhosis over 20-30 years.
- New all-oral treatment regimens that do not require interferon are highly effective. Sofosbuvir-based combinations can achieve over 90% sustained virologic response rates.
- Treatment is now recommended for most patients with chronic HCV to prevent long-term complications like cirrhosis and liver cancer. However, costs remain very high, with prices over $80,000 for a
HEPATITIS C
This document provides information about Hepatitis C, including how it is transmitted, symptoms, diagnosis, treatment, and prevention. Some key points:
- Hepatitis C is a contagious liver disease caused by the hepatitis C virus that can range from mild to serious and lifelong.
- It is mostly transmitted through exposure to infectious blood, such as through contaminated medical equipment or injecting drug use.
- Most infected people do not show symptoms, though some may experience fatigue, abdominal pain, and jaundice. Chronic infection can lead to cirrhosis or liver cancer.
- Diagnosis involves antibody and RNA testing to confirm. People at high risk should be screened.
- Treatment involves antiviral therapy with
Spectrum of HCV infection
This lecture is about Spectrum of HCV infection presented by Dr. Muhammad Mostafa Abdel Ghaffar, Head of Tropical Medicine Department, Ahmed Maher Teaching Hospital.
The lecture was presented in the scientific meeting of Internal and Tropical Medicine departments, Ahmed Maher Teaching Hospital titled (Towards Eradication of HCV in Egypt) in celebration of World Hepatitis Day on July 28, 2016.
https://www.facebook.com/AMTH.IM
https://www.facebook.com/events/1072758396145209/
http://www.no4c.com
Hepatitis c.2019
A 45-year-old woman presented with fatigue, weakness, loss of appetite, and slight anemia. Liver function tests showed elevated AST, ALT, and bilirubin levels. An ultrasound found a slightly decreased liver size without nodules or cirrhosis. A liver biopsy revealed inflammation and bridging fibrosis. This suggests a probable diagnosis of chronic hepatitis C infection, which can be confirmed with a HCV RNA test. The best course of action would be to start pharmacotherapy to treat the infection according to guidelines and educate the patient on prevention measures.
laboratory diagnosis of viral hepatitis (B & C)
This document discusses diagnostic evaluation of viral hepatitis. It provides an overview of hepatitis, describing it as inflammation of the liver that can be caused by infectious viruses, bacteria, fungi, parasites, or non-infectious factors like alcohol, drugs or metabolic diseases. The major hepatotropic viruses that cause hepatitis - hepatitis A, B, C, D and E viruses - are described. The document also discusses a case study of a patient presenting with symptoms of hepatitis and the appropriate serological tests to order. It provides guidance on interpreting the test results and diagnosing the type of hepatitis.
Hepatitis C Infection Anand Medicos
To create awareness about Generics treatment and make it available worldwide. My Aim is to raise awareness about hepatitis c treatment and generic. Visit here: http://anandmedicos.com/
Hepatitis b
The document discusses hepatitis B virus (HBV) and hepatitis B. It provides definitions and details about the epidemiology, transmission, clinical manifestations, pathogenesis, and serologic and virologic markers of HBV infection. Some key points include:
- HBV is a viral infection of the liver that affects around 2 billion people worldwide and causes over 1 million deaths annually.
- It is transmitted through contact with infectious blood or body fluids from an infected person.
- Clinical manifestations range from an acute self-limiting illness to chronic lifelong infection associated with cirrhosis and liver cancer.
- HBV pathogenesis involves the virus gaining entry into liver cells and using the host cell machinery to replicate. The host immune
Hepatitis c
Hepatitis C is a global health problem that causes 700,000 deaths per year. In Bangladesh, 1% of the population has HCV. New guidelines recommend screening high-risk groups and treating with direct-acting antiviral drugs, which have cure rates over 90% and shorter treatment durations compared to previous interferon-based regimens. Proper treatment can prevent cirrhosis, liver cancer and death from HCV. While challenges remain, scientists hope to eliminate HCV globally by 2030 with new pan-genotypic drugs. Prevention through injection safety, screening blood products, and educating healthcare workers is also important to control the disease.
HCV- Hepatitis and Hepatitis C Infection
Hepatitis C Virus and Infection. History, Source and Mode of Infection, Types of infection, Factors promoting severity, Laboratory Diagnosis of Hepatitis C, ELISA, References.
Hepatitis c.diagnosis and management
This document provides information about hepatitis C virus (HCV) including its structure, genome, genotypes, epidemiology, transmission, pathogenesis, diagnosis, and management. It discusses:
- HCV has a single-stranded RNA genome within the Flaviviridae family. It exists as different genotypes that determine treatment response.
- HCV is a major cause of liver disease worldwide, with transmission primarily through blood exposure. Diagnosis involves antibody and RNA testing.
- Treatment aims to eradicate HCV and involves pegylated interferon and ribavirin combinations. Response is monitored via viral load decline. Adverse effects require monitoring and management. New direct-acting antivirals are improving treatment outcomes.
Hcv
Hepatitis C is a global problem caused by the hepatitis C virus (HCV). HCV is a blood-borne virus that infects approximately 200 million people worldwide. Laboratory testing plays an important role in diagnosing HCV, evaluating patients for treatment, monitoring patients during treatment, and following up after treatment. There are 6 major genotypes of HCV with genotypes 1 and 4 being more difficult to treat and less responsive to interferon-based therapy.
Hepatitis c. diagnosis and treatment.assld guidelines.2016 .2017
A 45-year-old woman presented with fatigue, weakness, loss of appetite, and anemia. Liver function tests showed elevated AST, ALT, and bilirubin levels indicating liver inflammation and damage. A liver biopsy revealed necroinflammation and fibrosis. This suggests a diagnosis of chronic hepatitis C, which would be confirmed by a positive HCV RNA test. The best course of action would be to treat the patient with direct-acting antiviral therapy to cure the hepatitis C infection, advise lifestyle changes to protect the liver, and monitor for complications like cirrhosis or liver cancer.
Hepatitis C : Complete Overview and Recent Updates 2019
Hepatitis C : Complete Overview and Recent Updates 2019 Introduction, Classification, Clinical features, Staging, Investigation, Management Guidelines, Drugs, Updates 2019 Heaptobiliary disorder Sheila Sherlok Harrison
Hepatitis b (hbv)
Hepatitis B is caused by the hepatitis B virus (HBV) and can cause both acute and chronic infection of the liver. It is transmitted through bodily fluids and from mother to child. Approximately 5% of the world has been infected with HBV. Chronic infection can lead to liver damage and cancer. Treatment focuses on suppressing HBV replication through antiviral drugs like lamivudine, adefovir dipivoxil, and entecavir. Vaccination provides active immunization against HBV infection.
HIV Required Training
The document provides information about HIV/AIDS and Hepatitis B. It discusses how HIV destroys the immune system over time. Both HIV and Hepatitis B can be transmitted through blood and certain body fluids. While Hepatitis B can cause liver damage, HIV targets the immune system. The document emphasizes confidentiality regarding HIV/AIDS status and prohibits discrimination against individuals with HIV/AIDS in schools and workplaces.
Hepatitis c
A 45-year-old woman presented with fatigue, weakness, and loss of appetite. Laboratory tests found elevated liver enzymes and HCV RNA. A liver biopsy showed severe inflammation and fibrosis. She was diagnosed with chronic hepatitis C based on her history of blood transfusion, laboratory results, and biopsy findings. The best course of action would be to treat her hepatitis C with pegylated interferon and ribavirin therapy to reduce liver damage and prevent progression to cirrhosis.
Hepatitis C Presentation 2014
Hepatitis C continues to infect individuals in Saskatchewan. While Hep-C may be treatable, untreated Hep-C is a significant health threat. Transmission routes include shared drug equipment, dry blood contact, exposure during vacations, tattoos or piercing, and exposure through personal items such as razors and toothbrushes.
Hepatitis c
El documento resume la prevalencia y generalidades de la hepatitis C. La prevalencia mundial es de entre 130-170 millones de personas infectadas crónicamente. En España, la prevalencia en la población general es de entre 1-2.6%. El virus presenta 6 genotipos y se transmite principalmente a través de exposición parenteral como transfusiones de sangre o inyecciones. El tratamiento incluye interferón y ribavirina u otros inhibidores de proteasas, con efectos adversos como anemia, depresión y trastornos tiroideos.
More Related Content
What's hot
Hepatitis c (hcv)
Hepatitis C is an infection caused by the hepatitis C virus (HCV), which attacks liver cells and causes liver inflammation.
Basics of Hepatitis C
Hepatitis C is a viral infection of the liver caused by the hepatitis C virus (HCV). HCV is a spherical enveloped RNA virus that exists in 7 genotypes globally. It has structural and non-structural proteins and can cause both acute and chronic liver disease. HCV is transmitted primarily through contaminated blood and reuse of injection needles. While most infected individuals are asymptomatic, chronic infection can progress to cirrhosis or liver cancer over decades. Newer direct-acting antiviral drugs can cure over 95% of HCV infections with shorter treatment durations.
Hepatitis c
Hepatitis C is a contagious liver disease that can range from a mild illness lasting a few weeks to a serious lifelong condition. Acute hepatitis C occurs within the first 6 months of exposure and often leads to chronic infection. Chronic hepatitis C can last a lifetime and significantly damage the liver, possibly causing cirrhosis or liver cancer. The virus is primarily spread through contact with infected blood and affects an estimated 3.2 million Americans, with baby boomers most at risk. While treatment is very effective at clearing the virus, hepatitis C was responsible for over 350,000 deaths worldwide in recent years.
Epidemiology of Hepatitis C Virus in Egypt; an overview
This lecture is about Epidemiology of HCV in Egypt presented by Prof. DeWolfe Miller, Professor of Epidemiology, Hawaii University.
The lecture was presented in the scientific meeting of Internal and Tropical Medicine departments, Ahmed Maher Teaching Hospital titled (Towards Eradication of HCV in Egypt) in celebration of World Hepatitis Day on July 28, 2016.
https://www.facebook.com/AMTH.IM
https://www.facebook.com/events/1072758396145209/
http://www.no4c.com
Hepatitis C Treatment Questions
This document discusses hepatitis C virus (HCV) and current treatment options. It provides the following key points:
- HCV is the most common blood-borne pathogen in the US, with around 3.2 million people chronically infected. Chronic infections often progress to cirrhosis over 20-30 years.
- New all-oral treatment regimens that do not require interferon are highly effective. Sofosbuvir-based combinations can achieve over 90% sustained virologic response rates.
- Treatment is now recommended for most patients with chronic HCV to prevent long-term complications like cirrhosis and liver cancer. However, costs remain very high, with prices over $80,000 for a
HEPATITIS C
This document provides information about Hepatitis C, including how it is transmitted, symptoms, diagnosis, treatment, and prevention. Some key points:
- Hepatitis C is a contagious liver disease caused by the hepatitis C virus that can range from mild to serious and lifelong.
- It is mostly transmitted through exposure to infectious blood, such as through contaminated medical equipment or injecting drug use.
- Most infected people do not show symptoms, though some may experience fatigue, abdominal pain, and jaundice. Chronic infection can lead to cirrhosis or liver cancer.
- Diagnosis involves antibody and RNA testing to confirm. People at high risk should be screened.
- Treatment involves antiviral therapy with
Spectrum of HCV infection
This lecture is about Spectrum of HCV infection presented by Dr. Muhammad Mostafa Abdel Ghaffar, Head of Tropical Medicine Department, Ahmed Maher Teaching Hospital.
The lecture was presented in the scientific meeting of Internal and Tropical Medicine departments, Ahmed Maher Teaching Hospital titled (Towards Eradication of HCV in Egypt) in celebration of World Hepatitis Day on July 28, 2016.
https://www.facebook.com/AMTH.IM
https://www.facebook.com/events/1072758396145209/
http://www.no4c.com
Hepatitis c.2019
A 45-year-old woman presented with fatigue, weakness, loss of appetite, and slight anemia. Liver function tests showed elevated AST, ALT, and bilirubin levels. An ultrasound found a slightly decreased liver size without nodules or cirrhosis. A liver biopsy revealed inflammation and bridging fibrosis. This suggests a probable diagnosis of chronic hepatitis C infection, which can be confirmed with a HCV RNA test. The best course of action would be to start pharmacotherapy to treat the infection according to guidelines and educate the patient on prevention measures.
laboratory diagnosis of viral hepatitis (B & C)
This document discusses diagnostic evaluation of viral hepatitis. It provides an overview of hepatitis, describing it as inflammation of the liver that can be caused by infectious viruses, bacteria, fungi, parasites, or non-infectious factors like alcohol, drugs or metabolic diseases. The major hepatotropic viruses that cause hepatitis - hepatitis A, B, C, D and E viruses - are described. The document also discusses a case study of a patient presenting with symptoms of hepatitis and the appropriate serological tests to order. It provides guidance on interpreting the test results and diagnosing the type of hepatitis.
Hepatitis C Infection Anand Medicos
To create awareness about Generics treatment and make it available worldwide. My Aim is to raise awareness about hepatitis c treatment and generic. Visit here: http://anandmedicos.com/
Hepatitis b
The document discusses hepatitis B virus (HBV) and hepatitis B. It provides definitions and details about the epidemiology, transmission, clinical manifestations, pathogenesis, and serologic and virologic markers of HBV infection. Some key points include:
- HBV is a viral infection of the liver that affects around 2 billion people worldwide and causes over 1 million deaths annually.
- It is transmitted through contact with infectious blood or body fluids from an infected person.
- Clinical manifestations range from an acute self-limiting illness to chronic lifelong infection associated with cirrhosis and liver cancer.
- HBV pathogenesis involves the virus gaining entry into liver cells and using the host cell machinery to replicate. The host immune
Hepatitis c
Hepatitis C is a global health problem that causes 700,000 deaths per year. In Bangladesh, 1% of the population has HCV. New guidelines recommend screening high-risk groups and treating with direct-acting antiviral drugs, which have cure rates over 90% and shorter treatment durations compared to previous interferon-based regimens. Proper treatment can prevent cirrhosis, liver cancer and death from HCV. While challenges remain, scientists hope to eliminate HCV globally by 2030 with new pan-genotypic drugs. Prevention through injection safety, screening blood products, and educating healthcare workers is also important to control the disease.
HCV- Hepatitis and Hepatitis C Infection
Hepatitis C Virus and Infection. History, Source and Mode of Infection, Types of infection, Factors promoting severity, Laboratory Diagnosis of Hepatitis C, ELISA, References.
Hepatitis c.diagnosis and management
This document provides information about hepatitis C virus (HCV) including its structure, genome, genotypes, epidemiology, transmission, pathogenesis, diagnosis, and management. It discusses:
- HCV has a single-stranded RNA genome within the Flaviviridae family. It exists as different genotypes that determine treatment response.
- HCV is a major cause of liver disease worldwide, with transmission primarily through blood exposure. Diagnosis involves antibody and RNA testing.
- Treatment aims to eradicate HCV and involves pegylated interferon and ribavirin combinations. Response is monitored via viral load decline. Adverse effects require monitoring and management. New direct-acting antivirals are improving treatment outcomes.
Hcv
Hepatitis C is a global problem caused by the hepatitis C virus (HCV). HCV is a blood-borne virus that infects approximately 200 million people worldwide. Laboratory testing plays an important role in diagnosing HCV, evaluating patients for treatment, monitoring patients during treatment, and following up after treatment. There are 6 major genotypes of HCV with genotypes 1 and 4 being more difficult to treat and less responsive to interferon-based therapy.
Hepatitis c. diagnosis and treatment.assld guidelines.2016 .2017
A 45-year-old woman presented with fatigue, weakness, loss of appetite, and anemia. Liver function tests showed elevated AST, ALT, and bilirubin levels indicating liver inflammation and damage. A liver biopsy revealed necroinflammation and fibrosis. This suggests a diagnosis of chronic hepatitis C, which would be confirmed by a positive HCV RNA test. The best course of action would be to treat the patient with direct-acting antiviral therapy to cure the hepatitis C infection, advise lifestyle changes to protect the liver, and monitor for complications like cirrhosis or liver cancer.
Hepatitis C : Complete Overview and Recent Updates 2019
Hepatitis C : Complete Overview and Recent Updates 2019 Introduction, Classification, Clinical features, Staging, Investigation, Management Guidelines, Drugs, Updates 2019 Heaptobiliary disorder Sheila Sherlok Harrison
Hepatitis b (hbv)
Hepatitis B is caused by the hepatitis B virus (HBV) and can cause both acute and chronic infection of the liver. It is transmitted through bodily fluids and from mother to child. Approximately 5% of the world has been infected with HBV. Chronic infection can lead to liver damage and cancer. Treatment focuses on suppressing HBV replication through antiviral drugs like lamivudine, adefovir dipivoxil, and entecavir. Vaccination provides active immunization against HBV infection.
HIV Required Training
The document provides information about HIV/AIDS and Hepatitis B. It discusses how HIV destroys the immune system over time. Both HIV and Hepatitis B can be transmitted through blood and certain body fluids. While Hepatitis B can cause liver damage, HIV targets the immune system. The document emphasizes confidentiality regarding HIV/AIDS status and prohibits discrimination against individuals with HIV/AIDS in schools and workplaces.
What's hot (19)
Epidemiology of Hepatitis C Virus in Egypt; an overview
Epidemiology of Hepatitis C Virus in Egypt; an overview
Hepatitis c. diagnosis and treatment.assld guidelines.2016 .2017
Hepatitis c. diagnosis and treatment.assld guidelines.2016 .2017
Hepatitis C : Complete Overview and Recent Updates 2019
Hepatitis C : Complete Overview and Recent Updates 2019
Viewers also liked
Hepatitis c
A 45-year-old woman presented with fatigue, weakness, and loss of appetite. Laboratory tests found elevated liver enzymes and HCV RNA. A liver biopsy showed severe inflammation and fibrosis. She was diagnosed with chronic hepatitis C based on her history of blood transfusion, laboratory results, and biopsy findings. The best course of action would be to treat her hepatitis C with pegylated interferon and ribavirin therapy to reduce liver damage and prevent progression to cirrhosis.
Hepatitis C Presentation 2014
Hepatitis C continues to infect individuals in Saskatchewan. While Hep-C may be treatable, untreated Hep-C is a significant health threat. Transmission routes include shared drug equipment, dry blood contact, exposure during vacations, tattoos or piercing, and exposure through personal items such as razors and toothbrushes.
Hepatitis c
El documento resume la prevalencia y generalidades de la hepatitis C. La prevalencia mundial es de entre 130-170 millones de personas infectadas crónicamente. En España, la prevalencia en la población general es de entre 1-2.6%. El virus presenta 6 genotipos y se transmite principalmente a través de exposición parenteral como transfusiones de sangre o inyecciones. El tratamiento incluye interferón y ribavirina u otros inhibidores de proteasas, con efectos adversos como anemia, depresión y trastornos tiroideos.
Hepatitis c
A 45-year-old woman presented with fatigue, weakness, and appetite loss. Laboratory tests found elevated liver enzymes, bilirubin, and HCV RNA. A liver biopsy showed severe inflammation and fibrosis. She was diagnosed with hepatitis C based on her history of blood transfusion and laboratory results. Treatment with antiviral therapy is recommended to prevent further liver damage from the hepatitis C infection.
Hepatitis ppt final
Hepatitis viruses include Hepatitis A, B, C, D, E, and G. Hepatitis A virus is transmitted through the fecal-oral route and causes an acute infection. Hepatitis B virus is transmitted through blood or bodily fluids and can cause either an acute or chronic infection. Hepatitis C virus is transmitted through blood exposure and commonly causes a chronic infection. Prevention strategies include vaccination, immunoglobulin treatment, and screening of blood donors.
Dr. aabha nagral management and prevention of hepatitis c
Hepatitis C remains a significant problem, infecting an estimated 12 million people in India. Rates of infection were historically higher in thalassemia patients due to multiple transfusions but have reduced since mandatory testing was implemented in 2001. However, ongoing transmission still occurs. Only a small proportion of infected thalassemia patients receive treatment due to challenges with side effects and cost. More effective and affordable oral treatments are urgently needed to improve outcomes for those with chronic Hepatitis C infection.
Mahra Nourbakhsh's presentation, Hepatitis C Virus #1
The document summarizes information about hepatitis C virus (HCV) infection globally and in Canada. It provides statistics showing that an estimated 169.7 million people worldwide have HCV infection, with the highest prevalence rates in Africa, Southeast Asia, and the Eastern Mediterranean. In Canada, an estimated 242,500 people have HCV infection, with 7,900 new cases estimated in 2007. The document then outlines various aspects of HCV including transmission routes, natural history, diagnostic tools, viral life cycle, immunopathogenesis, progression of liver disease, and potential mechanisms of hepatic steatosis associated with HCV.
Mahra Nourbakhsh's presentation, hepatitis C virus #2
HCV particles circulate in association with lipoproteins and contain viral and host components. They enter cells by interacting with receptors involved in lipoprotein metabolism, including SR-BI, LDL-R, and GAGs. Lipid droplets aid primary HCV assembly. HCV hijacks the VLDL assembly and secretion pathway to exit cells and produce new viral particles.
Hepatitis c
La hepatitis C es una enfermedad infecciosa del hígado causada por el virus de la hepatitis C. Se transmite principalmente a través de la sangre. Afecta a aproximadamente 170 millones de personas en todo el mundo. La infección crónica por el virus puede provocar cirrosis o cáncer de hígado. No existe una vacuna efectiva, pero el tratamiento con interferón y ribavirina puede eliminar el virus en muchos pacientes.
EPIDEMIOLOGY OF HEPATITIS B AND C
The document provides information about hepatitis B and C, including:
- Hepatitis B and C are major global health problems, infecting hundreds of millions of people worldwide.
- Transmission occurs through contact with infected blood or bodily fluids, especially from infected mothers to babies during childbirth or from shared needles.
- Symptoms can range from mild to severe liver damage. While most adults recover from hepatitis B, chronic infection is more common in children and can lead to serious complications like liver cancer.
Virus de la hepatitis c (2)
1) La hepatitis C es causada por el virus de la hepatitis C, el cual puede causar inflamación del hígado, dañar las células hepáticas a largo plazo y provocar cirrosis o cáncer de hígado.
2) El virus se transmite principalmente a través de la sangre y los grupos de mayor riesgo incluyen usuarios de drogas inyectables y personal de la salud.
3) El diagnóstico incluye pruebas de sangre para detectar anticuerpos e ARN del virus, y una biopsia hepática puede us
Hepatitis Presentation
The document discusses the different types of hepatitis viruses. It states that hepatitis A, B, and C are the most common types, which can be contracted through contaminated food/water or bodily fluids. Hepatitis A has a vaccine that is given in two doses six months apart, while hepatitis B has a three dose vaccine series. There is currently no approved vaccine for hepatitis C. The document provides information on symptoms of the different hepatitis types and vaccines.
Hepatitis B
La hepatitis B es una enfermedad del hígado causada por el virus de la hepatitis B que puede causar procesos agudos o crónicos, incluso cirrosis, cáncer de hígado o muerte. Se transmite a través del contacto con sangre o fluidos corporales infectados. Su diagnóstico se realiza mediante análisis de sangre y biopsia hepática. Su tratamiento incluye medicamentos como el interferón o trasplante de hígado en casos graves, y su prevención mediante vacunación de bebés y grupos de
Hepatitis B
El documento describe la hepatitis B, un virus que causa inflamación del hígado y puede provocar enfermedad aguda o crónica. Se transmite a través de la sangre y fluidos corporales. Actualmente causa entre 250.000 y 500.000 muertes al año. Existe vacuna que previene la infección y debe administrarse a recién nacidos de madres infectadas.
Hepatitis B Virus
Hepatitis B is a viral infection that affects the liver and can cause both acute and chronic disease. It is transmitted through bodily fluids and is preventable through vaccination. Acute hepatitis B usually clears up on its own within 6 months, while chronic hepatitis B can last a lifetime if left untreated. Complications of chronic hepatitis B include cirrhosis, liver cancer, and liver failure. Hepatitis B is a major global health problem and vaccination is the most effective way to prevent its spread.
Adequacy criteria for cytology specimens by Mahra Nourbakhsh
This document discusses criteria for determining the adequacy of cytology specimens from various organs. It states that there is no simple answer to what constitutes an adequate sample as adequacy depends on factors like the sampling technique, operator skill, organ sampled, and characteristics of the lesion. For many organs, it provides numerical guidelines for minimum cellularity requirements but notes these should be considered case-by-case. It also emphasizes that adequacy criteria are not well established for some sites like salivary gland and kidney and that discordant clinical/imaging findings may call a sample's adequacy into question.
Mahra Nourbakhsh's poster, Hepatitis C Virus #3
This document discusses how hepatitis C virus (HCV) infection may lead to hepatic steatosis (fatty liver) by impairing the secretion of very low density lipoproteins (VLDL) from the liver. The author hypothesizes that HCV infection results in impaired VLDL secretion, leading to intracellular accumulation of triglycerides in the liver and steatosis. Experiments show that HCV infection decreases the activity of microsomal triglyceride transfer protein and cellular lipases, which are required for triglyceride mobilization and VLDL assembly, thereby impairing the secretion of newly synthesized and preformed apolipoprotein B-100, a major component of VLDL. This impaired V
Presentation onhepatitis
This document provides information on hepatitis, including its definition, causes, types, clinical manifestations, diagnosis, and management. Hepatitis is defined as inflammation of the liver that is commonly caused by viral infections such as hepatitis A, B, C, D, and E. It can also be caused by alcohol, drugs, fatty liver disease, or malnutrition. Hepatitis is characterized by liver inflammation and damage and can be acute (lasting less than 6 months) or chronic (lasting more than 6 months). Diagnosis involves liver enzyme tests, imaging, and liver biopsy. Management focuses on prevention, vaccination, drug therapy, nutrition, rest, and nursing care to prevent transmission and promote liver healing.
Hepatitis C & HIV Co-Infection
Hepatitis C is a liver disease caused by the hepatitis C virus. It is transmitted through exposure to infected blood, most commonly through sharing needles or other drug use equipment. Only about one-third of people show symptoms during initial infection, which may include fatigue, abdominal pain, and jaundice. Most people go on to develop chronic hepatitis C infection without symptoms for many years. Advanced liver disease from hepatitis C may lead to complications like jaundice, ascites, bleeding, and liver cancer. Co-infection with HIV increases the challenges of diagnosing and treating hepatitis C.
Hepatitis c virus
HCV is a heterogeneous virus with 11 known genotypes that causes hepatitis and can lead to cirrhosis or liver cancer. It enters liver cells by attaching to receptors and fusing with the cell membrane, then replicates by translating its RNA into viral proteins and using its own replication machinery to make new viral RNA and package new virus particles. Diagnosis can be difficult because primary infection may be asymptomatic, so additional virological tests are needed beyond normal liver enzyme levels. Current treatments include ribavirin with protease inhibitors like telaprevir or NS5B inhibitors like sofosbuvir, but treatment length depends on virus genotype and can have side effects.
Viewers also liked (20)
Dr. aabha nagral management and prevention of hepatitis c
Dr. aabha nagral management and prevention of hepatitis c
Mahra Nourbakhsh's presentation, Hepatitis C Virus #1
Mahra Nourbakhsh's presentation, Hepatitis C Virus #1
Mahra Nourbakhsh's presentation, hepatitis C virus #2
Mahra Nourbakhsh's presentation, hepatitis C virus #2
Adequacy criteria for cytology specimens by Mahra Nourbakhsh
Adequacy criteria for cytology specimens by Mahra Nourbakhsh
Similar to Hepatitis C Presentation for CHOW 2011
Hepatitis C Treatment in Pune- Kaizen Gastro Care
"Get effective Hepatitis C treatment at Kaizen Gastro Care in Pune. Our expert team provides comprehensive care and advanced therapies for Hepatitis C. Regain your health with personalized treatment plans. Book a consultation today.
"
What is Hepatitic C its effects
Hepatitis C is an infectious disease caused by the hepatitis C virus (HCV) that primarily affects the liver. HCV is spread through contact with infected blood, such as through intravenous drug use, unsafe medical procedures, and sexual or household contact with an infected person. Most people infected with HCV develop chronic hepatitis C, where the virus remains in the body, often for life. Chronic hepatitis C can cause serious damage to the liver, leading to complications like cirrhosis or liver cancer. While there is no vaccine, hepatitis C can be cured through antiviral treatment. Prevention focuses on avoiding contact with infected blood and getting tested if engaging in risky behaviors.
Hepatitis C: The Controversial Sexually Transmitted Infection
Hepatitis C: The Controversial Sexually Transmitted InfectionPlanned Parenthood Advocates of Wisconsin
This presentation was part of Embody's Safe Healthy Strong 2015 conference on sexuality education (www.ppwi.org/safehealthystrong). Embody is Planned Parenthood of Wisconsin's education and training programs. Learn more: www.ppwi.org/embody
DESCRIPTION
This workshop will outline the basics of Hepatitis C virus including a brief history, symptoms, and treatment.
The majority of the presentation will focus on the ways that HCV can be sexually transmitted. We will also talk about the increased risk of HCV for men who have sex with men (MSM) who are HIV positive, the lack of research around women who have sex with women’s (WSW) risk for HCV transmission, and the general controversy of calling HCV an STI.
ABOUT THE PRESENTERS
Rachael Cooper currently works as a Prevention Specialist at the AIDS Resource Center of Wisconsin and has worked in HIV/AIDS prevention and education both in Wisconsin and abroad. One of her current projects focuses heavily on educating at-risk populations about Hepatitis C transmission, symptoms, and care.
Veronica Shaheen is an Opiate Overdose Prevention Specialist, providing harm reduction services to
injection drug users at the AIDS Resource Center of Wisconsin (ARCW) LifePoint program by helping active users remove their personal risk for HIV, HCV, and other STIs. She also dedicates her time to overdose
prevention education and Naloxone training to any members of the community willing to help stop overdose deaths.Hepatitis C: Symptoms, Causes and Treatment
Hepatitis C is a viral infection that leads to liver inflammation and can sometimes lead to severe liver damage.
Phc hepatitis, son
Hepatitis A is an acute infectious disease of the liver caused by the hepatitis A virus. It is transmitted through ingestion of contaminated food or water or direct contact with an infected person. Symptoms include fatigue, fever, abdominal pain, and jaundice. There is no treatment, but vaccination provides effective prevention.
10 and Counting: Hepatitis A in San Diego
10 and Counting: Hepatitis A in San Diego
Darcy Wooten MD, MS
August 4, 2017
UCSD HIV & Global Health Rounds
Hepatitis c
Hepatitis C virus (HCV) infection is the most common chronic bloodborne infection in the United States, with approximately 3.2 million people chronically infected. HCV accounts for 40% of chronic liver disease and is the most common cause of liver transplant in the country. Genotype 1 is the most prevalent worldwide, accounting for 70% of HCV cases in the United States. HCV transmission occurs primarily through blood exposures like transfusions, injection drug use, and medical equipment reuse. The average incubation period is 6-7 weeks, though 90% of infected individuals test antibody positive within 5 months.
Viral hepatitis
Hepatitis is an inflammation of the liver that is usually caused by a viral infection. There are 5 main types of viral hepatitis: A, B, C, D, and E. Hepatitis A and E are typically transmitted through ingestion of contaminated food or water. Hepatitis B, C and D can be transmitted through contact with infected blood or bodily fluids. While hepatitis A only causes a short-term illness, hepatitis B and C can develop into chronic conditions that lead to serious liver problems like cirrhosis and cancer. Laboratory tests are used to diagnose hepatitis and detect the specific virus, and nursing care focuses on rest, diet, medication management, and health education to prevent transmission and complications.
Hep C Connection Presentation for 9Health Fair Site Leaders
Hep C Connection is partnering with 9Health Fair to provide hepatitis C antibody screening at several sites in spring 2015. They will assist with education and testing sign-up. Anyone born between 1945-1965 should get a one-time hepatitis C screening, as baby boomers account for most chronic cases in the US. Most people infected have no symptoms, so testing is important even with just one risk factor like past injection drug use. A positive antibody test requires a follow up viral load test to confirm infection status.
Viral hepatitis preconference session
This document provides an overview and objectives for a course on integrating viral hepatitis prevention and control messages into counseling sessions. The course covers an overview of the liver and viral hepatitis types A-E, focuses on hepatitis C transmission and prevention, and reviews guidelines for viral hepatitis testing and vaccination. The goal is to enhance counseling skills to create opportunities to discuss viral hepatitis during sessions.
Viral hepatitis preconference session
This document provides an overview and objectives for a course on integrating viral hepatitis prevention and control messages into counseling sessions. The course aims to enhance the counseling skills of health workers. It covers defining the liver and types of hepatitis, focusing on hepatitis C, and testing and vaccination guidelines. The document includes information on transmission routes, at-risk groups, disease burden, and prevention for hepatitis A, B, C, D and E.
Hepatitis C -.pdf
Hepatitis C is a virus that causes inflammation in the liver. Hepatitis C is still present, yet the patient is ignorant of it. It is only decades later that it is detectable through normal medical exams. Hepatitis C is spread via sharing needles and contaminated blood.
Hepatitis ppt
Infective Hepatitis can be acute or chronic depending on duration. Acute hepatitis may resolve on its own or progress to chronic hepatitis or rarely acute liver failure. Chronic hepatitis can progress to cirrhosis, liver failure, or cancer. Hepatitis is commonly caused by viral infections including hepatitis A, B, C, D, and E. Hepatitis A spreads through the fecal-oral route while hepatitis B, C, and D spread through blood and bodily fluids. Symptoms vary but often include fatigue, jaundice, abdominal pain, and nausea. Treatment depends on the type of hepatitis.
Viral Hepatitis Viral Hepatitis
1) A 29-year-old woman presented with jaundice, abdominal pain, and nausea/vomiting. Her liver enzymes were elevated and ultrasound showed a normal liver. She was diagnosed with acute hepatitis A.
2) A 38-year-old man with a history of elevated liver enzymes presented with mildly elevated enzymes. He tested positive for hepatitis B and C markers, indicating chronic hepatitis C infection.
3) Hepatitis C is a major cause of liver disease in the US, infecting an estimated 4 million people, with 30,000 new infections annually and 12,000-15,000 deaths from hepatitis C each year.
Hepatitis C
Hepatitis C is a disease that affects the liver and is caused by the hepatitis C virus (HCV). Approximately 3.2 million people in the United States are thought to have chronic hepatitis C. The virus replicates in the liver and triggers an immune response that can lead to liver scarring and loss of function over many years. Most people develop a chronic HCV infection, though some clear the virus early on. Hepatitis C is diagnosed through antibody and RNA tests to detect the virus. There is no vaccine and many people are unaware they are infected.
what is Hepatitis
Hepatitis C is a disease that affects the liver and is caused by the hepatitis C virus (HCV). Approximately 3.2 million people in the United States are thought to have chronic hepatitis C. The virus replicates in the liver and triggers an immune response that can lead to liver scarring and loss of function over many years. Most people develop a chronic HCV infection, though some clear the virus early on. Hepatitis C is diagnosed through antibody and RNA tests to detect the virus. There is no vaccine and many people are unaware they are infected.
what is Hepatitis C
Hepatitis C is a disease that affects the liver caused by the hepatitis C virus (HCV). Approximately 3.2 million people in the US have chronic hepatitis C. The virus replicates in the liver and triggers an immune response that can cause scarring and loss of liver function over many years. Most people develop a chronic HCV infection. Hepatitis C is diagnosed through an antibody test to detect past infection and an RNA test to detect the current presence of the virus. There is no vaccine and many people are unaware they are infected.
Hepatitis c
Hepatitis C is a liver disease caused by the hepatitis C virus. It is usually spread when someone comes into contact with infected blood, such as through sharing needles or from an infected mother during birth. Many people with hepatitis C do not show any symptoms, so the only way to know if someone is infected is to get tested. Left untreated, chronic hepatitis C can lead to serious health problems like liver damage, liver failure, and liver cancer. However, treatments are now available that can cure most people with hepatitis C within 8 to 12 weeks.
Std noon conf 2019
This document discusses sexually transmitted diseases (STDs) including epidemiology data from international, US, and Washington state sources. It provides CDC screening guidelines and details on prevention, clinical presentations, diagnosis, and treatment of common STDs like chlamydia, gonorrhea, HIV, herpes, syphilis, and human papillomavirus. Key points emphasized include taking a sexual history for all patients, vaccinating for HPV and HBV, testing all appropriate sites for STDs, and treating and testing partners of those with certain infections.
Hepatitis ppt
Viral hepatitis can be acute or chronic depending on whether symptoms last less than or more than six months. The main causes are infectious hepatitis viruses like hepatitis A, B, C, D, and E. Hepatitis A spreads through the fecal-oral route while hepatitis B, C, and D spread through blood and body fluids. Many people infected with hepatitis B or C do not show symptoms but can develop chronic liver disease and cancer over time. Vaccines exist for hepatitis A and B but not for C, D, and E. Treatment focuses on managing symptoms for acute cases and antiviral drugs for chronic cases.
Similar to Hepatitis C Presentation for CHOW 2011 (20)
Hepatitis C: The Controversial Sexually Transmitted Infection
Hepatitis C: The Controversial Sexually Transmitted Infection
Hep C Connection Presentation for 9Health Fair Site Leaders
Hep C Connection Presentation for 9Health Fair Site Leaders
Recently uploaded
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Histololgy of Female Reproductive System.pptx
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
The Electrocardiogram - Physiologic Principles
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.share - Lions, tigers, AI and health misinformation, oh my!.pptx
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Efficacy of Avartana Sneha in Ayurveda
Avartana Sneha is a unique method of Preparation of Sneha Kalpana in Ayurveda, mainly it is indicated for the Vataja rogas.
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd Edition by DeMarco, Walsh, Verified Chapters 1 - 25, Complete Newest Version TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd Edition by DeMarco, Walsh, Verified Chapters 1 - 25, Complete Newest Version TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd Edition by DeMarco, Walsh, Verified Chapters 1 - 25, Complete Newest Version Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Pdf Chapters Download Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Pdf Download Stuvia Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Study Guide Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Ebook Download Stuvia Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Questions and Answers Quizlet Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Studocu Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Quizlet Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Stuvia Community and Public Health Nursing: Evidence for Practice 3rd Edition Pdf Chapters Download Community and Public Health Nursing: Evidence for Practice 3rd Edition Pdf Download Course Hero Community and Public Health Nursing: Evidence for Practice 3rd Edition Answers Quizlet Community and Public Health Nursing: Evidence for Practice 3rd Edition Ebook Download Course hero Community and Public Health Nursing: Evidence for Practice 3rd Edition Questions and Answers Community and Public Health Nursing: Evidence for Practice 3rd Edition Studocu Community and Public Health Nursing: Evidence for Practice 3rd Edition Quizlet Community and Public Health Nursing: Evidence for Practice 3rd Edition Stuvia Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Pdf Chapters Download Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Pdf Download Stuvia Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Study Guide Questions and Answers Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Ebook Download Stuvia Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Questions Quizlet Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Studocu Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Quizlet Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Stuvia
Identifying Major Symptoms of Slip Disc.
Our backs are like superheroes, holding us up and helping us move around. But sometimes, even superheroes can get hurt. That’s where slip discs come in.
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS). Parc Taulí. Sabadell
Adhd Medication Shortage Uk - trinexpharmacy.com
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Recently uploaded (20)
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Hepatitis C Presentation for CHOW 2011
- 1. CHOW: Viral Hepatitis Hepatitis Education Project 911 Western Avenue, Suite 302 Seattle, WA
- 2. Hepatitis Topics What are the hepatitis viruses? Hepatitis C transmission Hepatitis C diagnosis and progression
- 3. Hepatitis viruses Hepatitis A Fecal-Oral Transmission Cycle Acute Infection Hepatitis B Transmitted through infected blood and bodily fluids (semen and vaginal fluids) Can be an acute or chronic infection Hepatitis C Transmitted through infected blood
- 4. Vaccine Preventable Hepatitis A vaccine 2 shots over six months lifelong protection Hepatitis B vaccine 3 shots over six months lifelong protection Combination hepatitis A/B vaccine 3 shots over six months or 4 shots over 12 months lifelong protection
- 6. Dialysis: contaminated medical equipment
- 9. Blood transfusion prior to 1992
- 13. Patient experiences For some (15-25%) hepatitis C will be an acute infection HCV antibodies are not protective 75-85% will develop chronic hepatitis C Some will never have a problem Some will get serious liver disease, including cirrhosis Hepatitis C continues to be the leading cause of liver transplantation in the U.S.
- 15. Insomnia
- 16. Depression
- 17. Joint pains
- 19. Types of hepatitis C Hepatitis C is like a family with 6 different siblings - Genotypes In the U.S. we have 3 different genotypes Genotype 1 Most common in the U.S. Genotypes 2 & 3
- 20. Testing positive, now what? Get blood tests to check liver function Check and monitor liver scarring (fibrosis) Abdominal ultrasound Liver biopsy Consider treatment